diphenylamine has been researched along with cyclin d1 in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Basso, A; Garraway, LA; Getz, G; Golub, TR; Lobo, JM; Osman, I; Pratilas, CA; Rosen, N; Sawai, A; Sebolt-Leopold, J; Sellers, WR; She, Y; Solit, DB; Ye, Q | 1 |
| Aboagye, EO; Aigbirhio, FI; Golovko, O; He, Q; Lees, M; Leyton, J; Nguyen, QD; Perumal, M; Smith, G; Workman, P | 1 |
| Halilovic, E; Pagliarini, R; Rosen, N; Sellers, WR; She, QB; Solit, DB; Ye, Q | 1 |
| Collins, MJ; Harrisingh, MC; Kerai, AP; Lloyd, AC; Napoli, I; Noon, LA; Parrinello, S; Ribeiro, S; Rosenberg, LH; White, IJ; Woodhoo, A | 1 |
| Agiostratidou, G; Anzovino, A; Chandiramani, N; Cohen, HW; Hazan, RB; Hulit, J; Kim, S; McDaid, HM; Nagi, C; Norton, L; Phillips, GR; Qian, X; Suyama, K; Yao, J | 1 |
5 other study(ies) available for diphenylamine and cyclin d1
| Article | Year |
|---|---|
BRAF mutation predicts sensitivity to MEK inhibition.
Topics: Animals; Benzamides; Cell Line, Tumor; Cell Proliferation; Cyclin D1; Diphenylamine; Female; G1 Phase; Humans; Mice; Mitogen-Activated Protein Kinase Kinases; Mutation; Phosphorylation; Proto-Oncogene Proteins B-raf; Xenograft Model Antitumor Assays | 2006 |
Noninvasive imaging of cell proliferation following mitogenic extracellular kinase inhibition by PD0325901.
Topics: Animals; Benzamides; Caspase 3; Cell Line, Tumor; Cell Proliferation; Cyclin D1; Dideoxynucleosides; Diphenylamine; Fluorescent Antibody Technique; Gene Expression Regulation, Neoplastic; Humans; Ki-67 Antigen; MAP Kinase Kinase 1; Mice; Mice, Inbred BALB C; Phosphorylation; Positron-Emission Tomography; RNA, Messenger; Thymidine Kinase; Xenograft Model Antitumor Assays | 2008 |
PIK3CA mutation uncouples tumor growth and cyclin D1 regulation from MEK/ERK and mutant KRAS signaling.
Topics: Alleles; Animals; Benzamides; Cell Growth Processes; Cell Line, Tumor; Class I Phosphatidylinositol 3-Kinases; Colonic Neoplasms; Cyclin D1; Diphenylamine; Extracellular Signal-Regulated MAP Kinases; Gene Knockout Techniques; HCT116 Cells; Humans; Lung Neoplasms; MAP Kinase Kinase Kinases; MAP Kinase Signaling System; Mice; Mutation; Pancreatic Neoplasms; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins p21(ras); ras Proteins | 2010 |
A central role for the ERK-signaling pathway in controlling Schwann cell plasticity and peripheral nerve regeneration in vivo.
Topics: Animals; Animals, Newborn; Benzamides; Cell Movement; Cyclin D1; Cytokines; Diphenylamine; Estrogen Antagonists; Gene Expression Regulation; Leukocytes; Male; MAP Kinase Signaling System; Mast Cells; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microscopy, Confocal; Microscopy, Electron, Transmission; Microscopy, Immunoelectron; Motor Activity; Myelin Sheath; Nerve Regeneration; Neutrophils; Peripheral Nerve Injuries; Proto-Oncogene Proteins c-raf; Reaction Time; Receptor, Nerve Growth Factor; Receptors, Estrogen; Recovery of Function; Schwann Cells; T-Lymphocytes; Tamoxifen; Time Factors | 2012 |
N-cadherin/FGFR promotes metastasis through epithelial-to-mesenchymal transition and stem/progenitor cell-like properties.
Topics: Aldehyde Dehydrogenase; Animals; Benzamides; Breast Neoplasms; Cadherins; Cell Movement; Cell Proliferation; Cyclin D1; Diphenylamine; Epithelial-Mesenchymal Transition; Extracellular Signal-Regulated MAP Kinases; Female; Humans; Lung Neoplasms; MAP Kinase Kinase 1; Mice; Mice, Transgenic; Neoplasm Invasiveness; Neoplasm Metastasis; Phosphorylation; Proto-Oncogene Proteins c-akt; Pyrimidines; Receptor, ErbB-2; Receptors, Fibroblast Growth Factor; RNA Interference; RNA, Small Interfering; Signal Transduction; Snail Family Transcription Factors; Spheroids, Cellular; Stem Cells; Transcription Factors; Tumor Cells, Cultured | 2014 |